Bladder Cancer: Understanding Immune-, Targeted-, and Antibody-Based Models for Patient Care
6 ビュー
• 07/18/23
0
0
埋め込む
administrator
加入者
Bladder Cancer: Understanding Immune-, Targeted-, and Antibody-Based Models for Patient Care
Chair, Matthew D. Galsky, MD, discusses bladder cancer in this CME/MOC activity titled “The Therapeutic Transformation of Bladder Cancer: Understanding Immune-, Targeted-, and Antibody-Based Models for Patient Care.” For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC information, and to apply for credit, please visit us at PeerView.com/EQF865. CME/MOC credit will be available until April 19, 2023.
もっと見せる
フェイスブックのコメント
SORT BY-
トップコメント
-
最新のコメント